133 related articles for article (PubMed ID: 18383862)
1. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Spyridonidou S; Neukam FW; Schlegel KA; Patsouris E
Anticancer Res; 2008; 28(1A):309-14. PubMed ID: 18383862
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
3. A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer.
Vairaktaris E; Yapijakis C; Nkenke E; Serefoglou ZC; Chatzitheofylaktou A; Vassiliou S; Derka S; Vylliotis A; Perrea D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4027-30. PubMed ID: 18225566
[TBL] [Abstract][Full Text] [Related]
4. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
[TBL] [Abstract][Full Text] [Related]
6. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
[TBL] [Abstract][Full Text] [Related]
7. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
[TBL] [Abstract][Full Text] [Related]
8. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
[TBL] [Abstract][Full Text] [Related]
9. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
[TBL] [Abstract][Full Text] [Related]
10. The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Stathopoulos P; Vassiliou S; Derka S; Nkenke E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):3981-6. PubMed ID: 18225559
[TBL] [Abstract][Full Text] [Related]
11. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Serefoglou Z; Vylliotis A; Ries J; Nkenke E; Wiltfang J; Derka S; Vassiliou S; Springer I; Kessler P; Neukam FW
Oral Oncol; 2006 Oct; 42(9):888-92. PubMed ID: 16730474
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Agapi C; Vassiliou S; Nkenke E; Antonis V; Sofia S; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4011-4. PubMed ID: 18225563
[TBL] [Abstract][Full Text] [Related]
15. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
[TBL] [Abstract][Full Text] [Related]
17. Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.
Vairaktaris E; Vassiliou S; Yapijakis C; Spyridonidou S; Vylliotis A; Derka S; Nkenke E; Fourtounis G; Neukam FW; Patsouris E
Oncol Rep; 2007 Dec; 18(6):1537-43. PubMed ID: 17982641
[TBL] [Abstract][Full Text] [Related]
18. The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.
Vairaktaris E; Yapijakis C; Nkenke E; Vassiliou S; Vylliotis A; Nixon AM; Derka S; Ragos V; Spyridonidou S; Tsigris C; Neukam FW; Patsouris E
Am J Hematol; 2007 Nov; 82(11):1010-2. PubMed ID: 17636471
[TBL] [Abstract][Full Text] [Related]
19. A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer.
Vairaktaris E; Vylliotis A; Spyridonodou S; Derka S; Vassiliou S; Nkenke E; Yapijakis C; Serefoglou Z; Neukam FW; Patsouris E
Anticancer Res; 2008; 28(1A):271-5. PubMed ID: 18383856
[TBL] [Abstract][Full Text] [Related]
20. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans.
Vairaktaris E; Yannopoulos A; Vassiliou S; Serefoglou Z; Vylliotis A; Nkenke E; Critselis E; Avgoustidis D; Yapijakis C; Neukam FW; Patsouris E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Dec; 104(6):796-802. PubMed ID: 17428692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
